AHR and chronic kidney disease: Compared with CKD mice that received MyoAAV-GFP, Ahr, Cyp1a1, and Ahrr mRNA levels were significantly reduced in the skeletal muscle of CKD mice that received MyoAAV-shAHR (Figure 4C).